Form 4: Cue Biopharma Executive Sells Shares
Insider Transaction (Form 4)
Michael Vincent Meluzio, VP, Prin. Accounting Officer of Cue Biopharma, Inc., sold 5,628 shares of common stock on August 13, 2026.
Summary
- Option exercise/conversion: acquired 13,647 Common Stock on August 13, 2026; holds 54,589 after (Direct).
- Open-market sale: disposed of 1,519 Common Stock at $29.37 ($44,613) on August 13, 2026; holds 53,070 after (Direct).
- Open-market sale: disposed of 4,106 Common Stock at $30.35 ($124,617) on August 13, 2026; holds 48,964 after (Direct).
- Open-market sale: disposed of 3 Common Stock at $31.13 ($93) on August 13, 2026; holds 48,961 after (Direct).
- Option exercise/conversion: disposed of 13,647 Common Stock on August 13, 2026; holds 27,295 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $169,324 of stock on the open market.
Insider Transactions
Michael Vincent Meluzio — Officer (VP, Prin. Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-13 | Option exercise/conversion | Common Stock | 13,647 | — | — | 54,589 |
| 2026-08-13 | Open-market sale | Common Stock | 1,519 | $29 | $44.6K | 53,070 |
| 2026-08-13 | Open-market sale | Common Stock | 4,106 | $30 | $124.6K | 48,964 |
| 2026-08-13 | Open-market sale | Common Stock | 3 | $31 | $93 | 48,961 |
| 2026-08-13 | Option exercise/conversion | Common Stock | 13,647 | — | — | 27,295 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-13 | Option exercise/conversion (13,647 shares) |
| 2026-08-13 | Open-market sale (1,519 shares) |
| 2026-08-13 | Open-market sale (4,106 shares) |
| 2026-08-13 | Open-market sale (3 shares) |
| 2026-08-13 | Option exercise/conversion (13,647 shares) |
Keywords
insider transaction, Form 4, CUE, Cue Biopharma, Inc., bearish, Michael Vincent Meluzio
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.